Holger Steuber

USPTO Granted Patents = 8 (Patent Applications = 8)

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 11.8

ph-index = 3

Forward Citations = 38(Granted Patents)

Company Filing History:

7 out of 378

Bayer Pharma Aktiengesellschaft

patents

1 out of 2

Bayer Pharma Aktiengessellschaft

patents

1 out of 12,157

Bayer Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2018-2024

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12006304 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs (2024-06-11),

2. 12006303 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs (2024-06-11),

3. 11161825 - 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides (2021-11-02),

4. 10793545 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs (2020-10-06),

5. 10435396 - 2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs (2019-10-08),

6. 10308634 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs (2019-06-04),

7. 10167293 - [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones (2019-01-01),

8. 9951086 - Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments (2018-04-24),

Title: Holger Steuber: Innovator in Pharmaceutical Chemistry

Introduction

Holger Steuber is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on substituted indazoles. With a total of eight patents to his name, Steuber's inventions are aimed at addressing various medical conditions.

Latest Patents

Holger Steuber's latest patents focus on novel substituted indazoles, which are crucial for the production of pharmaceutical preparations. These patents detail methods for the production of these compounds and their applications in treating and preventing diseases. Specifically, his work targets conditions such as endometriosis, rheumatoid arthritis, multiple sclerosis, and various other disorders. The innovative approaches outlined in his patents aim to improve the efficacy of treatments for these challenging health issues.

Career Highlights

Throughout his career, Holger Steuber has worked with notable companies, including Bayer Pharma Aktiengesellschaft. His experience in the pharmaceutical industry has allowed him to develop groundbreaking solutions that enhance patient care and treatment outcomes. His dedication to research and development has positioned him as a key figure in the field.

Collaborations

Holger Steuber has collaborated with esteemed colleagues, including Holger Siebeneicher and Ulrich Bothe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Holger Steuber's contributions to pharmaceutical chemistry through his patents on substituted indazoles demonstrate his commitment to advancing medical science. His work not only addresses critical health issues but also showcases the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.